etomoxir has been researched along with Benign Neoplasms, Brain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bianchetti, E; Bruce, JN; Canoll, P; Humala, N; Karpel-Massler, G; Kleiner, G; Mahajan, A; Mela, A; Nguyen, TTT; Quinzii, CM; Sanchez-Quintero, MJ; Shang, E; Shu, C; Siegelin, MD; Torrini, C; Westhoff, MA; Zhang, Y; Zhao, J | 1 |
Affleck, VS; Joshi, AR; Lin, H; Maxwell, R; Patel, S; Stoll, EA; Turnbull, DM; Wilson, I | 1 |
Croteau, NJ; Ferrick, DA; Pike, LS; Smift, AL; Wu, M | 1 |
3 other study(ies) available for etomoxir and Benign Neoplasms, Brain
Article | Year |
---|---|
MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carnitine; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Crizotinib; Drug Synergism; Epoxy Compounds; Fatty Acids; Gene Expression Profiling; Glioblastoma; Glycolysis; Guanidines; Humans; Lactams, Macrocyclic; Metabolomics; Mice; Mitochondria; Mitochondrial Dynamics; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proteomics; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2020 |
Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Proliferation; Epoxy Compounds; Fatty Acids; Glioma; Glycolysis; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Neural Stem Cells; Oxidation-Reduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.
Topics: Adenosine Triphosphate; Brain Neoplasms; Cell Death; Down-Regulation; Drug Evaluation, Preclinical; Epoxy Compounds; Fatty Acids; Glioblastoma; Humans; Hypoglycemic Agents; Models, Biological; NADP; Oxidation-Reduction; Reactive Oxygen Species; Tumor Cells, Cultured; Up-Regulation | 2011 |